Syndrome in question
- PMID: 26734879
- PMCID: PMC4689086
- DOI: 10.1590/abd1806-4841.20153818
Syndrome in question
Abstract
Morbihan Syndrome is a rare entity with unknown etiology. It is clinically characterized by chronic erythematous edema on the face - especially in the middle and upper third of the face - and creates abnormal facial contours that are initially intermitent but become permanent with the development of the syndrome. The histopathology is nonspecific and its therapy is a major challenge due to poor response to the various treatment options. We present the case of a male patient with a five-month-history of disease.
Conflict of interest statement
Conflict of Interest: None
Figures



References
-
- Smith AL, Cohen DE. Successful long-term use of oral isotretinoin for the management of Morbihan Disease. Arch Dermatol. 2012;148:1395–1398. - PubMed
-
- Romiti N. Morbus Morbihan: solid and persistent facial edema and erythema. An Bras Dermatol. 2000;75:599–603.
-
- Franco M, Parra IH, Bibiloni N, Kowalczuk A, Galimberti R. Enfermidad de Morbihan. Dermatol Argent. 2009;15:434–436.
-
- Estudillo ZFB, Gómez MIR, Ibarra MML, Ramírez MJQ. Edema sólido facial persistente relacionado com acne (Morbihan) Dermatol Rev Mex. 2012;56:341–345.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical